The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human autologous CAR-T for metastatic breast cancers to target growth factor receptor MUC1*.
 
Cynthia Carol Bamdad
Employment - Minerva Biotechnologies
Leadership - Minerva Biotechnologies
Stock and Other Ownership Interests - Minerva Biotechnologies
Research Funding - Minerva Biotechnologies
Patents, Royalties, Other Intellectual Property - Minerva Biotechnologies
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology
 
Yuan Yuan
Consulting or Advisory Role - AstraZeneca; Diiachi; Genentech; Merck; Stemline Therapeutics; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Gilead Sciences; Merck
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Jennifer M. Specht
Honoraria - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Sensei Biotherapeutics
Consulting or Advisory Role - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Lyell Immunopharma Inc; Sensei Biotherapeutics; Volastra Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Carisma Therapeutics (Inst); Cascadian Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; GE Healthcare; GlaxoSmithKline; Nektar
 
Andrew K. Stewart
Employment - Minerva Biotechnologies
 
Benoit J. Smagghe
Employment - Minerva Biotechnologies
 
Stephen Chi-Min Lin
No Relationships to Disclose
 
Mark G. Carter
Employment - Minerva Biotechnologies
 
Timothy W. Synold
No Relationships to Disclose
 
Vishwas Parekh
Consulting or Advisory Role - Genentech/Roche
 
Danica M. Walkley
Employment - Minerva Biotechnologies
 
Qing Liu-Michael
No Relationships to Disclose
 
Kevin R. Yi
Employment - Minerva Biotechnologies
Patents, Royalties, Other Intellectual Property - Minerva Biotechnologies
 
Jac-Leen Nash
Employment - Minerva Biotechnologies
 
Michael J. Nash
Employment - Minerva Biotechnologies
 
Stanley R. Hamilton
Research Funding - CytoImmune Therapeutics (Inst); Intima (Inst); Iovance Biotherapeutics (Inst); Minerva Biotechnologies (Inst)
 
Stephen J. Forman
Stock and Other Ownership Interests - Lixte Biotechnology; MustangBio
Consulting or Advisory Role - Alimera Sciences; Lixte Biotechnology; MustangBio; MustangBio
Research Funding - MustangBio
Patents, Royalties, Other Intellectual Property - MustangBio